Royal Bank of Canada’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-217
| Closed | – | – | 7846 |
|
|
2022
Q4 | $0 | Buy |
217
+208
| +2,311% | +$26 | ﹤0.01% | 8075 |
|
|
2022
Q3 | $0 | Buy |
+9
| New | +$2 | ﹤0.01% | 8159 |
|
|
2022
Q1 | – | Sell |
-5,000
| Closed | -$12K | – | 8214 |
|
|
2021
Q4 | $12K | Buy |
+5,000
| New | +$14.8K | ﹤0.01% | 7015 |
|
|
2021
Q3 | – | Sell |
-3,620
| Closed | -$20K | – | 8036 |
|
|
2021
Q2 | $20K | Hold |
3,620
| – | – | ﹤0.01% | 6579 |
|
|
2021
Q1 | $19K | Hold |
3,620
| – | – | ﹤0.01% | 6465 |
|
|
2020
Q4 | $12K | Hold |
3,620
| – | – | ﹤0.01% | 6313 |
|
|
2020
Q3 | $7K | Sell |
3,620
-5,000
| -58% | -$11.5K | ﹤0.01% | 6063 |
|
|
2020
Q2 | $22K | Buy |
8,620
+5,000
| +138% | +$9.03K | ﹤0.01% | 5560 |
|
|
2020
Q1 | $6K | Sell |
3,620
-5
| -0.1% | -$10 | ﹤0.01% | 6006 |
|
|
2019
Q4 | $2K | Buy |
3,625
+1
| +0% | +$1 | ﹤0.01% | 6595 |
|
|
2019
Q3 | $4K | Sell |
3,624
-3
| -0.1% | -$4 | ﹤0.01% | 6143 |
|
|
2019
Q2 | $5K | Sell |
3,627
-4
| -0.1% | -$6 | ﹤0.01% | 6351 |
|
|
2019
Q1 | $6K | Hold |
3,631
| – | – | ﹤0.01% | 6231 |
|
|
2018
Q4 | $4K | Buy |
3,631
+3,620
| +32,909% | +$6.25K | ﹤0.01% | 6271 |
|
|
2018
Q3 | $0 | Buy |
+11
| New | +$24 | ﹤0.01% | 7068 |
|
|
2018
Q1 | – | Sell |
-1
| Closed | – | – | 6957 |
|
|
2017
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 7035 |
|
|
2017
Q3 | $0 | Buy |
+1
| New | +$3 | ﹤0.01% | 7092 |
|
|
2016
Q1 | – | Sell |
-2,620
| Closed | -$9K | – | 6753 |
|
|
2015
Q4 | $9K | Buy |
+2,620
| New | +$10.6K | ﹤0.01% | 6008 |
|
|
2014
Q2 | – | Sell |
-1,750
| Closed | -$24K | – | 6204 |
|
|
2014
Q1 | $24K | Hold |
1,750
| – | – | ﹤0.01% | 5135 |
|
|
2013
Q4 | $41K | Hold |
1,750
| – | – | ﹤0.01% | 4974 |
|
|
2013
Q3 | $55K | Hold |
1,750
| – | – | ﹤0.01% | 4768 |
|
|
2013
Q2 | $55K | Buy |
+1,750
| New | +$60.2K | ﹤0.01% | 4616 |
|
Other funds holding STAB
Royal Bank of Canada's STAB Position: Q1 2023 in Review
Royal Bank of Canada sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2023, closing a stake of 217 shares.
Royal Bank of Canada first reported a position in STAB in Q2 2013 and held it in 22 quarters. The position peaked at $55K in Q3 2013. 4 funds tracked by Wall St. Rank hold STAB as of Q1 2023.
- Royal Bank of Canada reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Royal Bank of Canada sold 217 Statera Biopharma, Inc. Common Stock shares in Q1 2023.
- Royal Bank of Canada first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 22 quarters.
- Royal Bank of Canada's Statera Biopharma, Inc. Common Stock position peaked at $55K in Q3 2013.
- 4 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2023.
Based on Royal Bank of Canada's 13F filing for Q1 2023, filed 15 May 2023.